Associate or Full Professor – Chicanx/Latinx Health and Wellness

first_imgDepartment SummaryThe Department of Chicana andChicano Studies (CCS) at San José State University (SJSU) seeksqualified applicants for a full-time Associate or Full Professorwith a specialization in the area of Chicanx/Latinx Health andWellness.CCS at SJSU was created in 1968, making it the oldest graduateprogram in Chicanx Studies in the country. Our mission is to serveSJSU students and diverse communities through an interdisciplinaryChicanx Studies program based on principles of social justice. Weoffer three degree programs: A master’s degree with emphases inPolicy, Education, and Comparative Ethnic Studies; a newundergraduate major with emphases in Cultural and CreativeExpression, Institutions and Community Engagement, andTransnationalism and Global Relations; and a popular undergraduateminor that draws students from across the university. Ourcurriculum prepares students to critically examine and creativelyrespond to intellectual traditions and contemporary issuesresulting from race, class, and gender intersections inChicanx/Latinx and other communities. Graduates of our program havelaunched careers in teaching, social services, public policy,health care, government, and community service, as well as pursuedadvanced degrees in programs such as Education, History, SocialWork, and Feminist Studies, becoming the next generation of CCSeducators and community leaders.Addressing the racial and ethnic realities of our students andcommunities, CCS has seen significant growth in recent years interms of both faculty hiring and student enrollment. CCS facultyregularly connect with students and our broader campus communitythrough an exciting new series of weekly Pláticas that highlighttheir wide-ranging interest and expertise. In addition, our facultyconnect their research and teaching to our campus and localcommunities through partnerships with the Chicanx/Latinx StudentSuccess Center, UndocuSpartan Center, Culture Counts ReadingSeries, Young Women’s Freedom Center, and more. As the flagshipEthnic Studies department within the College of Social Sciences(CoSS), CCS is a vital part of SJSU.SJSU and CoSS are committed to growing Ethnic Studies more broadly.In 2018, CoSS launched the Ethnic Studies Collaborative (ESC),bringing together faculty, staff, and students to highlight theresearch and leadership contributions of SJSU’s Ethnic Studiesprograms and departments. The ESC includes the Department ofAfrican American Studies, Department of Chicana and ChicanoStudies, and the Program of Asian American Studies; it serves asthe nexus for Ethnic Studies faculty, student, and communitycollaboration at SJSU. The ESC supports Ethnic Studies curricularand co-curricular projects that address issues of settlercolonialism, racial capitalism, immigration, and racialization,with a focus on the comparative histories and experientialknowledges of marginalized racial and ethnic groups in the U.S.,including but not limited to Native Americans/American Indians;Black and African Americans; Chicanxs and Latinxs; NativeHawaiians, Pacific Islanders, and Indigenous peoples of Oceania andother nations; and Asian Americans. The ESC is also currentlyplaying a key role in shaping the implementation of AB 1460, theCSU graduation requirement in Ethic Studies.Required Qualifications Compensation – Commensurate with qualifications andexperience. See Benefits Summary for details.Starting Date – August 2021Eligibility – Employment is contingent upon proof ofeligibility to work in the United States.Application ProcedureClick Apply Now to complete the SJSU Online Employment Applicationand attach the following documents by February 1, 2021 for fullconsideration: Preferred Qualifications Develop and teach courses in Chicanx/Latinx Health and Wellnessat both the undergraduate and graduate levels that align with theapplicant’s training and interests.Engage in student recruitment and retention efforts.Support the development of the CSU Ethnic Studies graduationrequirement through course development and advising. This workinvolves crossing disciplines and active engagement with diversegroups and individuals.Scholarly and professional contributions are expected fortenure and promotion.Participate in shared governance, usually in department,college, and university committee and other serviceassignments.Demonstrate awareness and experience understanding the needs ofa student population of great diversity – in age, culturalbackground, ethnicity, primary language and academic preparation –through inclusive course materials, teaching strategies andadvisement. A Ph.D. (or equivalent) from an accredited institution inChicanx/Latinx Studies, public health, sociology of health, medicalanthropology, health policy or related fieldsDemonstrated commitment to teaching excellenceA record of research productivity, as might be demonstratedthrough peer-reviewed publications or presentations appropriate foran associate or full professorDemonstrated communication and interpersonal skillsDemonstrated awareness of and sensitivity to the educationalgoals of a multicultural population as might have been gained incross-cultural study, training, teaching and other comparableexperience. Administrative or managerial experience (for example, programdevelopment, budget oversight, supervising office staff,etc.) Responsibilities letter of interestcurriculum vitaestatement of teaching interests/philosophy (2 pages)statement of research plans (2 pages)diversity statement (2 pages)three references with contact information Inquires may be directed to Professor Maria Luisa Alaniz, Chair ofRecruitment Committee ( [email protected] ).The UniversitySan José StateUniversity enrolls over 35,700 students, a significantpercentage of whom are members of minority groups. As such, thisposition is for scholars interested in a career at a nationalleader in graduating URM students. SJSU is a Hispanic ServingInstitution (HSI) and Asian American and Native American PacificIslander (AANAPISI) Serving Institution; 40% of our students arefirst-generation, and 38% are Pell-qualified. The university iscurrently ranked third nationally in increasing student upwardmobility. The University is committed to increasing the diversityof its faculty so our disciplines, students, and the community canbenefit from multiple ethnic and gender perspectives.San José State University is California’s oldest institution ofpublic higher learning. Located in downtown San José (Pop.1,000,000) in the heart of Silicon Valley, SJSU is part of one ofthe most innovative regions in the world. As Silicon Valley’spublic university, SJSU combines dynamic teaching, research, anduniversity-industry experiences to prepare students to address thebiggest problems facing society. SJSU is a member of the 23-campusCalifornia State University (CSU) system.Equal Employment StatementSan José State University is an Affirmative Action/EqualOpportunity Employer. We consider qualified applicants foremployment without regard to race, color, religion, nationalorigin, age, gender, gender identity/expression, sexualorientation, genetic information, medical condition, maritalstatus, veteran status, or disability. This policy applies to allSan José State University students, faculty, and staff as well asUniversity programs and activities. Reasonable accommodations aremade for applicants with disabilities who self-disclose. Note thatall San José State University employees are considered mandatedreporters under the California Child Abuse and Neglect ReportingAct and are required to comply with the requirements set forth inCSU Executive Order 1083 as a condition of employment.Additional InformationA background check (including a criminal records check) must becompleted satisfactorily before any candidate can be offered aposition with the CSU. Failure to satisfactorily complete thebackground check may affect the application status of applicants orcontinued employment of current CSU employees who apply for theposition.Advertised: November 27, 2020 (9:00 AM) Pacific StandardTimeApplications close:last_img read more

Press release: Three further batches of blood pressure and heart medication recalled from pharmacies

first_img Email [email protected] News centreMHRA10 South ColonnadeLondonE14 4PU Our priority as regulator is to make sure the medicines you and your family take are effective and acceptably safe. This recall shows we are continuing to investigate potential contamination of sartan containing medicines. There is no evidence at present that medicines containing NDMA, NDEA or NMBA have caused any harm to patients and this recall is a precautionary measure. Because of the risk associated with suddenly stopping high blood pressure medication, continue to take your medicines as prescribed by your doctor. Please speak to your doctor or pharmacist if you have any concerns about your medicine. Media enquiries Out of office hours: 07770 446 189 (17:00 – 08:30)center_img During office hours: 020 3080 7651 (08:30 – 17:00) Office hours are Monday to Friday, 8:30am to 5pm. For real-time updates including the latest press releases and news statements, see our Twitter channel at https://www.twitter.com/mhragovuk As a precautionary measure to protect public health, the Medicines and Healthcare products Regulatory Agency (MHRA) today recalled 3 batches of Losartan tablets due to contamination with the nitrosamine N-nitroso-N-methylamino butyric acid (NMBA). The affected batches can be viewed here.The recall is taking place as part of the continued investigation into potential nitrosamine contamination of sartan containing medicines, a class of medicine to treat blood pressure and heart attacks and heart failures.Currently there is no evidence that nitrosamine impurities can cause harm and patients are being advised to continue taking their medication.The investigation into possible contamination of sartan medicines began in 2018, after the nitrosamine N-nitrosodimethylamine (NDMA), was identified in valsartan manufactured at a facility based in China.Last year, the MHRA recalled batches of valsartan containing tablets to pharmacy level in July and November due to possible NDMA and N-nitrosodiethylamine (NDEA) contamination.In January and February 2019 the MHRA recalled batches of irbesartan containing tablets after testing revealed possible contamination with NDEA.The MHRA continues to monitor the situation in the UK and are comprehensively investigating the issue alongside the European Medicines Agency (EMA) and the European Directorate for the Quality of Medicines (EDQM).Bernadette Sinclair-Jenkins, MHRA’s Manager, Regulatory Assessment Unit of the Inspection, Enforcement and Standards Division, said:last_img read more